Boston Scientific Corp.

A panel of medical experts recommended Wednesday that federal health regulators approve Boston Scientific's stroke-prevention device.

U.S regulators said Monday that the surgery required to implant Boston Scientific's anti-stroke device might reduce its effectiveness and said more careful review is needed before making an approval decision.

Natick-based Boston Scientific Corp. has received approval from the U.S. Food and Drug Administration (FDA) on its new stent system designed to treat coronary heart disease.

Boston Scientific has completed its acquisition of a division of the Lowell-based electrophysiology business of C.R. Bard, which the Natick-based medical device manufacturer said could significantly boost its capabilities in the fast-growing market for advanced electrophysiology procedures.

A day after it said it would cut up to 1,500 jobs over the next two years, and on the same day it announced a third-quarter loss of $5 million, Boston Scientific said its chief financial officer will leave after the end of the year.

Boston Scientific plans to eliminate 1,100 to 1,500 positions worldwide over the next two years, the Natick-based medical device company announced Wednesday.

The first of 6,400 lawsuits against Boston Scientific (BSX) regarding the Natick-based company's transvaginal mesh devices will go to trial March 10, a lower-court judge ruled last week.

Just as Boston Scientific wrapped up a years-long fight over stent patents, the Natick-based medical device manufacturer was hit with another suit by the family of the inventor of the pacemaker, alleging a secret deal.

A medical device made by Boston Scientific of Natick that's used to treat severe forms of asthma has been shown to be safe and effective, according to data published online in a medical journal.

Boston Scientific is offering more than $1 billion in debt notes to help pay earlier debt that was borrowed at a higher interest rate, the Natick-based medical device manufacturer announced.